Goldman Sachs Group Inc Immatics N.V. Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Immatics N.V. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,987,292 shares of IMTX stock, worth $11.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,987,292
Previous 1,987,292 -0.0%
Holding current value
$11.5 Million
Previous $8.96 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$4.18 - $7.42 $1.64 Million - $2.92 Million
-393,114 Reduced 16.51%
1,987,292 $8.96 Million
Q4 2024

Feb 11, 2025
BUY
$6.73 - $11.21 $15.3 Million - $25.4 Million
2,266,141 Added 1983.23%
2,380,406 $16.9 Million
Q3 2024

Nov 14, 2024
SELL
$10.93 - $12.92 $17.9 Million - $21.2 Million
-1,638,090 Reduced 93.48%
114,265 $1.3 Million
Q2 2024

Aug 13, 2024
SELL
$9.78 - $13.49 $556,618 - $767,769
-56,914 Reduced 3.15%
1,752,355 $20.4 Million
Q1 2024

May 15, 2024
BUY
$10.23 - $12.94 $2.66 Million - $3.37 Million
260,360 Added 16.81%
1,809,269 $19 Million
Q4 2023

Feb 13, 2024
BUY
$7.36 - $10.89 $8.71 Million - $12.9 Million
1,183,860 Added 324.3%
1,548,909 $16.3 Million
Q3 2023

May 14, 2024
SELL
$11.01 - $12.62 $13 Million - $14.9 Million
-1,183,860 Reduced 76.43%
365,049 $4.23 Million
Q3 2023

Nov 14, 2023
BUY
$11.01 - $12.62 $3.29 Million - $3.77 Million
298,910 Added 451.94%
365,049 $4.23 Million
Q2 2023

May 14, 2024
SELL
$5.92 - $12.72 $96,377 - $207,081
-16,280 Reduced 19.75%
66,139 $763,000
Q2 2023

Aug 14, 2023
SELL
$5.92 - $12.72 $96,377 - $207,081
-16,280 Reduced 19.75%
66,139 $763,000
Q1 2023

May 14, 2024
SELL
$6.74 - $9.44 $26,339 - $36,891
-3,908 Reduced 4.53%
82,419 $568,000
Q1 2023

May 11, 2023
SELL
$6.74 - $9.44 $26,339 - $36,891
-3,908 Reduced 4.53%
82,419 $568,000
Q4 2022

May 14, 2024
SELL
$8.05 - $11.58 $212,584 - $305,804
-26,408 Reduced 23.42%
86,327 $751,000
Q4 2022

Feb 13, 2023
SELL
$8.05 - $11.58 $212,584 - $305,804
-26,408 Reduced 23.42%
86,327 $751,000
Q3 2022

May 14, 2024
SELL
$3.31 - $13.06 $4.75 Million - $18.8 Million
-1,436,174 Reduced 92.72%
112,735 $1.13 Million
Q3 2022

Nov 10, 2022
BUY
$3.31 - $13.06 $373,152 - $1.47 Million
112,735 New
112,735 $1.13 Million
Q2 2022

Aug 15, 2022
SELL
$6.0 - $9.37 $151,458 - $236,526
-25,243 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$6.64 - $12.85 $6,115 - $11,834
921 Added 3.79%
25,243 $202,000
Q4 2021

Feb 14, 2022
BUY
$10.81 - $14.38 $129 - $172
12 Added 0.05%
24,322 $327,000
Q3 2021

Nov 10, 2021
BUY
$11.58 - $15.46 $281,509 - $375,832
24,310 New
24,310 $316,000

Others Institutions Holding IMTX

# of Institutions
82
Shares Held
91.5M
Call Options Held
201K
Put Options Held
109K
View Full List

About Immatics N.V.

IMTX Quotes by TradingView
  • Ticker IMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,227,000
  • Market Cap $441M
  • Description
  • Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...
More about IMTX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email